Determination of Total Homocysteine
To the Editor: The determination of total homocysteine (tHcy) for the diagnosis and therapy of folate and cobalamin (vitamin B 12 ) deficiencies has become an important feature of the clinical chemistry laboratory. In addition, because of the potential use of tHcy as an independent risk factor for cardiovascular disease and thromboembolism, the establishment of accurate and reliable tHcy assays has gained importance. As a result, a number of different analytical protocols to measure tHcy concentrations in human serum or plasma, using HPLC and gas chromatography/mass spectrometry (GC/MS) techniques have been described (1) . A recent article by Frantzen et al. (2) described an enzyme conversion immunoassay (EIA) for measurement of tHcy in plasma or serum. This assay is based on enzymatic conversion of tHcy (after reduction and release of endogenous homocysteine from proteins and/or disulfides) to S-adenosyl-lhomocysteine (SAH) by the action of SAH hydrolase (EC 3.3.1.1), followed by quantification of SAH in a competitive immunoassay with use of a monoclonal antibody against SAH. Frantzen et al. demonstrated a good method quality and showed their results obtained by the new assay to be well-correlated with a commonly used HPLC method (3) (as cited in (2)). They emphasized that the enzymatic method may serve as an alternative to HPLC analysis in clinical routines and research.
We performed a systematic comparison of the new EIA (available from Axis Biochemicals ASA, Oslo) and the GC/MS methods published by Stabler et al. (4) and, more recently, by our group (5) . We determined the concentrations of tHcy by these methods in plasma samples of 104 volunteers (ages, 20 -69 years; 43 females, 61 males; tHcy range, 1.60 -82.34 mol/L) with good precision (intra-and interassay CVs were Ͻ6.2% and Ͻ8.0%, respectively, for the EIA and Ͻ3.5% and Ͻ4.8%, respectively, for the GC/MS methods). The EIA and GC/MS methods agreed well (Table 1) , with results of the GC/MS methods 1% higher than the EIA results. This may be regarded as good agreement with the enzymatic method.
The new EIA has an acceptable precision and analysis range. It is quick and simple to use and can be adopted immediately by any laboratory. It appears to be an excellent choice for most routine laboratory purposes, particularly for monitoring of oral folate, betaine, and/or pyridoxine therapy, as well as for large clinical studies on the role of tHcy as a cardiovascular risk factor. On the other hand, the advantages of the GC/MS methods are, despite their cumbersomeness, their excellent lower limits of quantification (ϳ0.2 mol/L by GC/MS), their extended analytical range (0.2-300 mol/L by GC/MS vs 2.0 -50 mol/L by EIA), and the possibility to determine simultaneously other metabolites of homocysteine turnover, e.g., cystathionine (4) and/or the other sulfur-containing amino acids, cysteine and methionine (5) . The latter is especially required when performing studies that aim at the response of tHcy concentrations to an oral methionine challenge in several metabolic disorders and diseases (6, 7) .
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Rapid, Stable Ambient Storage of Leukocyte RNA from Whole Blood
To the Editor: The purification of intact RNA is the first critical step for mRNA analysis. Because of the instability of RNA, the process requires labor-intensive multiple steps while guarding against RNases. Although many techniques and commercial kits are available, these are techniques for research laboratories and are not suitable when RNA is collected from patients in clinics, hospitals, operating rooms, or even the emergency room and stored until use.
Here we report a rapid method for the preparation of RNA from blood. Mononuclear leukocytes were first separated by conventional density gradient centrifugation or equivalent methods. The cell suspensions were filtered through glass fiber membranes, and the resultant membranes were immediately dried under vacuum. After dried membranes were stored at room temperature for 1 week, RNA was isolated by acid-gua-nidine/phenol/chloroform (AGPC) extraction (1) . As a control, cell suspensions were centrifuged, and pellets were homogenized by AGPC. The quality of RNA was tested by three criteria: (a) agarose gel electrophoresis to confirm 18S and 28S rRNA bands (2), (b) measurement of total mRNA by the method we developed (3), and (c) reverse transcription-PCR (RT-PCR) (4) of glyceraldehyde-3-phosphate dehydrogenase (G3PDH) mRNA. As a result, rRNAs and G3PDH-specific mRNA in dried samples were stable at room temperature for 1 week (Fig.  1A) , and the amount of total mRNA was similar to that of the control (mean Ϯ SE, 5.3 Ϯ 0.4 vs 4.6 Ϯ 0.6 g/L blood). More importantly, RNA was easily released from membranetrapped cells by simply passing them through AGPC solution, whereas vigorous homogenization (pipetting/vortex-mixing) was required to recover RNA from cell pellets in control experiments.
In contrast to mononuclear leukocytes, whole blood is much more difficult to handle, probably because of the presence of RNase-rich granulocytes. The stability of RNA may be improved by selective lysis of erythrocytes before recovery of the nucleated cells by centrifugation (5) . In the present study, erythrocytes were selectively lysed in hypotonic solution followed by filtration through glass fiber filter membranes. When celltrapped membranes were dried and were stored at room temperature, we identified substantial amounts of degradation of RNA, although some rRNA bands remained (data not shown). We also tested various organic solvents to accelerate drying in conjunction with RNase inhibitors, but none of the procedures prevented RNA degradation (data not shown). We then applied a denaturing solution [4 mol/L guanidine thiocyanate, 25 mmol/L sodium citrate, 5 g/L N-lauroylsarcosine (Na salt, Sarkosyl), and 0.1 mol/L 2-mercaptoethanol] to the membranes immediately after cells were trapped, and the RNA-containing passthrough fraction (guanidinium-stabilized RNA) was stored at room temperature for 2 weeks. RNA was then isolated by phenol/chloroform extraction.
As shown in Fig. 1B , we obtained high-quality RNA even after a 2-week storage period at room temperature in terms of rRNA bands in agarose gel electrophoresis (Fig. 1B,  upper panel) and RT-PCR of G3PDH ( Fig. 1B, lower panel) . Furthermore, there were no differences in the amounts of total mRNA among 0, 1, 7, and 14 days after ambient storage (mean Ϯ SE, 16.2 Ϯ 3.9, 15.7 Ϯ 1.5, 13.8 Ϯ 3.2, and 14.5 Ϯ 3.0 g/L blood, respectively). In control experiments, leukocytes were pelleted by centrifugation, followed by conventional RNA extraction (1) . However, we could recover neither rRNA ( Fig. 1B, upper panel) nor mRNA from whole blood (Ͻ1 g/L blood), and subsequent RT-PCR failed to amplify G3PDH mRNA (Fig. 1B,  lower panel) .
By capturing cells with glass fiber membranes, we could eliminate centrifugation, which is a major hurdle when assay automation is considered. Furthermore, this method overcomes the problems of irreproducibility of homogenization of cell pellets. In the case of mononuclear cells, the storage of RNA on dried membrane is convenient, and the membranes are easily transported to test/research facilities from the clinical sites. We hope this methodology 
